Page 106 - Abt News Today

Canandaigua National Bank & Trust Co. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,482 shares of the healthcare product maker’s stock after selling 718 […]

Gries Financial LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,040 shares of the healthcare product maker’s stock after selling 535 shares during the period. Gries […]

Arcblock (ABT) traded down 0.5% against the U.S. dollar during the one day period ending at 20:00 PM E.T. on September 12th. One Arcblock token can now be purchased for $0.0738 or 0.00000285 BTC on popular cryptocurrency exchanges. In the last week, Arcblock has traded 3.5% lower against the U.S. dollar. Arcblock has a total […]

Prudent Investors Network Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,164 shares of the healthcare product maker’s stock after selling 174 shares during the quarter. Abbott Laboratories accounts […]

GSB Wealth Management LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,756 shares of the healthcare product maker’s stock after selling 313 shares during the period. GSB Wealth Management […]

Putnam Investments LLC lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,289,805 shares of the healthcare product maker’s stock after acquiring an additional 63,394 shares during the period. Putnam […]

Harvest Investment Advisors LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.0% in the 1st quarter, Holdings Channel.com reports. The firm owned 13,477 shares of the healthcare product maker’s stock after acquiring an additional 515 shares during the quarter. Harvest Investment Advisors LLC’s holdings in Abbott Laboratories were worth […]

Garde Capital Inc. reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 7.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,660 shares of the healthcare product maker’s stock after selling 126 shares during the period. Garde Capital Inc.’s holdings in Abbott […]

Garde Capital Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,660 shares of the healthcare product maker’s stock after selling 126 shares during the quarter. Garde Capital […]

Harvest Investment Advisors LLC lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,477 shares of the healthcare product maker’s stock after buying an additional 515 shares during the […]